CD44-targeted N-benzyltetrahydroisoquinoline derivatives as anticancer agents with high tumor-to-normal cell selectivity.
Autores: Romero-Tamudo S, Carrión MD, Chayah M, Espejo-Román JM, Domene C, Sánchez-Martín RM, Cruz-López O, Conejo-García A
08/2025 - European journal of medicinal chemistry